| | | | | |
CRL Charles River Laboratories International, Inc. | €161,22 | +1,41 % | €7,87B | €209,82K | |
| €60,1001 | -0,71 % | €7,85B | €447,94K | |
| €273,62 | +2,67 % | €7,85B | €129,30K | |
ABVX Abivax SA American Depositary Shares | €86,0836 | -1,42 % | €7,85B | €880,40K | |
| €8,5132 | +3,98 % | €7,84B | €16,97M | |
| €636,72 | +1,49 % | €7,84B | €132,51K | |
LLYVK Liberty Live Holdings, Inc. Series C Liberty Live Group Common Stock | €87,1115 | +0,53 % | €7,82B | €134,14K | |
| €24,0915 | +1,73 % | €7,80B | €1,24M | |
NCLH Norwegian Cruise Line Holdings Ltd. Ordinary Shares | €18,1259 | +4,84 % | €7,77B | €7,82M | |
LLYVA Liberty Live Holdings, Inc. Series A Liberty Live Group Common Stock | €83,8114 | +0,58 % | €7,77B | €39,07K | |
CORT Corcept Therapeutics Inc. | €70,2969 | -1,37 % | €7,76B | €253,44K | |
| €166,87 | +7,44 % | €7,75B | €100,31K | |
CIG.C Companhia Energetica De Minas Gerais-CEMIG | €2,6148 | -3,88 % | €7,74B | €2,71K | |
UHS Universal Health Services, Inc. Class B | €123,39 | +0,18 % | €7,72B | €579,35K | |
| €39,3715 | +0,06 % | €7,72B | €538,17K | |
